戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 chieved following transfection of cells by a retrovirus vector.
2 vo with the NOD/SCID mouse system using onco-retrovirus vector.
3  receptor (sFlt-1) on N202.1A cells, using a retrovirus vector.
4 ession of Gata4, Mef2c, and Tbx5 (GMT) using retrovirus vectors.
5  and in chickens using replication-competent retrovirus vectors.
6 mbryonic and postnatal cerebral cortex using retrovirus vectors.
7 etochore requires transfection of cells by a retrovirus vector, a step that is potentially mutagenic.
8 udy, using busulfan conditioning and an SFFV retrovirus vector, achieved more than 20% marking in 2 p
9 -globin capable of efficient expression in a retrovirus vector and form the basis for further refinem
10                               Interaction of retrovirus vectors and endogenous retroviruses present i
11 nts was then investigated using MoMuLV-based retrovirus vectors and HIV-1-based lentivirus vectors.
12  Moloney murine leukemia virus (MoMLV)-based retrovirus vectors and that such vectors can transduce h
13  aimed at the preparation of tissue-targeted retrovirus vectors and will also aid in studies of nucle
14 oduced into normal bone marrow cells through retrovirus vectors, and neutrophils expressing this muta
15                                  Recombinant retrovirus vectors are widely used for gene transfer stu
16                          We show here that a retrovirus vector bearing the JSRV Env is stable during
17  genes were constructed and used to generate retrovirus vectors bearing corresponding Env proteins.
18 ared the binding and infectivity patterns of retrovirus vectors bearing either FeLV-B-90Z or FeLV-B-G
19 ty characteristics not only over amphotropic retrovirus vectors but also over genetically tropism-mod
20 opoietic stem cells (HSCs) transduced with a retrovirus vector carrying an activated ABL oncogene can
21                                              Retrovirus vectors constructed using the murine stem cel
22  retroviral DNA upon arrested cells when the retrovirus vector contained the corresponding binding mo
23                         We previously used a retrovirus vector containing a cDNA cassette encoding hu
24                        We have used a murine retrovirus vector containing an enhanced green fluoresce
25 eatment with a self-inactivating (SIN) gamma-retrovirus vector containing deletions in viral enhancer
26 4(+) cells from these patients using an MFGS retrovirus vector containing the gamma(c) gene IL2RG pse
27 owth factors and transduced with recombinant retrovirus vectors containing allogeneic (n=4) or syngen
28                              Using MFG-based retrovirus vectors containing oxidase genes, we have pre
29 le that this novel ecotropic-based conjugate retrovirus vector could also potentially provide enhance
30 old differences in levels of expression of a retrovirus vector depending on its site of insertion in
31              Recombinant lentivirus, but not retrovirus vectors, effectively transduced SP cells that
32 ation of an adenovirus to a c-kit-retargeted retrovirus vector enables retroviral transduction.
33 o fibroblasts to an excess of an amphotropic retrovirus vector encoding alkaline phosphatase results
34 ic neurons using diphtheria toxin (DT) and a retrovirus vector encoding DT receptor abolished the ben
35 (+) cells were transduced with an MFGS-based retrovirus vector encoding mCD24 using 4 daily transduct
36 eral blood-mobilized stem cells (PBSCs) with retrovirus vector encoding wild-type (wt) CXCR4 or WHIM-
37 ines displayed varying capacities to produce retrovirus vectors even at the same transduction efficie
38                         In addition, a novel retrovirus vector expressing an HBcAg-neomycin phosphotr
39  a Moloney murine leukemia virus-based gamma-retrovirus vector expressing interleukin-2 receptor gamm
40 till became senescent after infection with a retrovirus vector expressing oncogenic Ha-Ras.
41                  CTLs were transduced with a retrovirus vector expressing the dominant-negative TGF-b
42 lls were transduced through infection with a retrovirus vector expressing the human telomerase cataly
43                       A panel of recombinant retrovirus vectors expressing different forms of the HBV
44                                              Retrovirus vectors expressing transdominant-negative mut
45 valent (H-2 IEalpha), were transduced with a retrovirus vector for swine DRalpha.
46 th this system resulted in the production of retrovirus vectors for more than 1 week and the long-ter
47 -globin locus control region could protect a retrovirus vector from position effects.
48 enous feline or human CXCR4 expressed from a retrovirus vector, indicating that experiments investiga
49                       Clonal analysis of the retrovirus vector-infected CEMSS cells showed that SAR-c
50 jections with 10(8) CFU of the LHBc-NEO(6A3) retrovirus vector into rhesus monkeys induced HBc/eAg-sp
51                             Gene transfer by retrovirus vectors into murine mucopolysaccharidosis VII
52 sduced with either SAR or non-SAR-containing retrovirus vectors, into 3 animals.
53 nclude that infection of mammary glands with retrovirus vectors is an efficient means to screen candi
54  Transduction by murine leukemia virus-based retrovirus vectors is limited in certain cell types, par
55 ells of the T cell line were inserted into a retrovirus vector linked by an oligonucleotide encoding
56 ed in the myeloblast cell line M1, using the retrovirus vector LXSN.
57  demonstrates that such modified pseudotyped retrovirus vectors may be useful reagents for studies of
58                 We conclude that these novel retrovirus vectors may be valuable for treating a variet
59 as carried out by topical application of two retrovirus vectors, MFGlacZ (10(7) blue forming units pe
60                 The expression of IRF-4 from retrovirus vectors morphologically transformed primary f
61  expression of HINT1 in these cells, using a retrovirus vector (pLNCX2) that encodes either wild-type
62 hed bone marrow stem cells transduced with a retrovirus vector preparation containing replication-com
63 on assay to directly compare GALV-pseudotype retrovirus vectors produced by either Phoenix-GALV or by
64 id amplicons to efficiently convert cells to retrovirus vector producer cells after single-step trans
65 ed on gibbon ape leukemia virus (GALV)-based retrovirus vector-producing cells.
66 o infection by a murine leukemia virus-based retrovirus vector pseudotyped with the MMTV envelope pro
67 xperiments in the presence of FN CH-296 with retrovirus vectors pseudotyped with the same or a differ
68                                            A retrovirus vector, PY31, was constructed to contain the
69 us, efficient transduction by an amphotropic retrovirus vector requires high-level expression of the
70 ion and extensive examination of a versatile retrovirus vector, RET (removable exon trap).
71                                              Retrovirus vector sequences encoding lacZ were cloned do
72  Moloney murine leukemia virus (MoMLV)-based retrovirus vector (SRalphaLEGFP).
73 omatitis virus G protein (VSV-G) pseudotyped retrovirus vector that was concentrated to high titer.
74 e inserted the Ank/(A)gamma-globin gene into retrovirus vectors that could transfer one or two copies
75 in red blood cells, we could generate stable retrovirus vectors that would express globin at sufficie
76                             When placed in a retrovirus vector, this cassette was also expressed at h
77 iological function of tenv, we used a murine retrovirus vector to produce amphotropic virions.
78 1 infection, we used a murine leukemia virus retrovirus vector to transduce and overexpress the cDNA
79            The potent ability of recombinant retrovirus vectors to induce HBcAg- and eAg-specific CTL
80 orders has been hampered by the inability of retrovirus vectors to transfer globin genes and their ci
81                                   The use of retrovirus vectors to transfer oxidase enzyme subunit cD
82 1-expressing VSV-G-pseudotyped lentivirus or retrovirus vectors under identical conditions.
83 ssion of Fpg in bone marrow (BM) cells via a retrovirus vector was associated with demonstrable 8-oxo
84                          This modified gamma-retrovirus vector was found to retain efficacy in the tr
85 Moloney murine leukemia virus (MoMuLV)-based retrovirus vectors was investigated in various settings.
86 udies amphotropic MFGS-gp91phox (murine onco-retrovirus vector) was used in a clinical trial of X-lin
87 ndividual myeloid colonies demonstrated that retrovirus vectors with FeLV-C and RD114 pseudotypes wer

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。